Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

TriSalus Life Sciences (TLSI) Other Working Capital Changes (2022 - 2025)

Historic Other Working Capital Changes for TriSalus Life Sciences (TLSI) over the last 4 years, with Q3 2025 value amounting to $129000.0.

  • TriSalus Life Sciences' Other Working Capital Changes fell 5671.14% to $129000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$1.3 million, marking a year-over-year decrease of 15415.95%. This contributed to the annual value of $1.7 million for FY2024, which is 26550.39% up from last year.
  • Latest data reveals that TriSalus Life Sciences reported Other Working Capital Changes of $129000.0 as of Q3 2025, which was down 5671.14% from -$266000.0 recorded in Q2 2025.
  • TriSalus Life Sciences' Other Working Capital Changes' 5-year high stood at $3.0 million during Q2 2024, with a 5-year trough of -$1.3 million in Q3 2023.
  • In the last 4 years, TriSalus Life Sciences' Other Working Capital Changes had a median value of -$29125.0 in 2022 and averaged $174666.7.
  • Within the past 5 years, the most significant YoY rise in TriSalus Life Sciences' Other Working Capital Changes was 373414.63% (2024), while the steepest drop was 693333.33% (2024).
  • Quarter analysis of 4 years shows TriSalus Life Sciences' Other Working Capital Changes stood at $1.3 million in 2022, then crashed by 99.3% to $9000.0 in 2023, then plummeted by 6933.33% to -$615000.0 in 2024, then surged by 120.98% to $129000.0 in 2025.
  • Its last three reported values are $129000.0 in Q3 2025, -$266000.0 for Q2 2025, and -$511000.0 during Q1 2025.